This HTML5 document contains 64 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58659611
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в травні 2006 scientific article published on 17 April 2006 im Mai 2006 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel artículu científicu espublizáu n'abril de 2006
p:P577
wds:Q58659611-F591ACC7-8A11-4389-BBFA-0313289488D7
wdt:P577
2006-04-17T00:00:00Z
p:P2093
wds:Q58659611-E8803A1B-012C-4721-B303-28A9D7E281C2 wds:Q58659611-013E9B93-3E59-4E94-9B62-B6B2A5DDCBE2 wds:Q58659611-29A245FC-FF64-4A4E-9925-EBCC6872D54E wds:Q58659611-3A0FABEF-B8C5-41BC-87BD-061E12359323 wds:Q58659611-55449354-5A3A-47E1-8C02-F25D156E0DC5 wds:Q58659611-9A6A5ED9-3DAB-4964-96A7-DE7A19602060 wds:Q58659611-7336145F-0F97-4234-AC39-3EB83D88C8AF wds:Q58659611-7D1298D9-E785-48C2-8269-AB0DEB979014 wds:Q58659611-C79007DA-A223-4A6B-998E-9430F668CDE1 wds:Q58659611-B944A6AC-9484-430E-998E-CB8C2179B93C wds:Q58659611-E79F8A96-0F7D-41F2-AB68-2DFC3553325A
wdt:P2093
Claire Goulvestre Jean-Benoit Arlet Olivier Benveniste Coralie Bloch-Queyrat Christian Pagnoux Marielle Atassi Dalia Dimitri Luc Mouthon Farhad Heshmati Thierry Maisonobe Serge Herson
rdfs:label
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP) Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle
skos:prefLabel
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP) Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle
schema:name
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP) Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle
p:P50
wds:Q58659611-3C1DFE80-16C9-48EB-A845-BBFE8BD353BE wds:Q58659611-B5AB7C13-2EFF-4420-8A9E-6287737F62EA wds:Q58659611-61ED8864-6BF6-4EFD-996A-746C31E05B29
wdt:P50
wd:Q88410079 wd:Q70896551 wd:Q39066473
p:P1476
wds:Q58659611-9A940FEF-019F-406B-AD6E-CC6E4D2E3A39
wdt:P1476
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)
p:P304
wds:Q58659611-22D988F8-9366-4419-AAFC-4E59A0F1065B
wdt:P304
334-336
p:P31
wds:Q58659611-516E881C-5C13-4383-904C-306FE97BE9ED
wdt:P31
wd:Q13442814
p:P921
wds:Q58659611-1383375E-398B-4AA4-9227-61358E8392BE wds:Q58659611-D55B4BCD-ED3F-4730-A290-3EF799599298
wdt:P921
wd:Q79460 wd:Q412323
p:P698
wds:Q58659611-D5F27EBB-F31C-4461-927B-E81960894B58
wdtn:P698
n11:16616848
wdt:P698
16616848
p:P1433
wds:Q58659611-6F481E28-EFDB-4E60-BF25-52A5E7819454
wdt:P1433
wd:Q1981326
p:P433
wds:Q58659611-C38F7E3B-C84C-4F05-9823-85B8714BF737
p:P478
wds:Q58659611-1256132A-0127-462F-AAA9-A82ABC5D8FB9
wdt:P433
5
wdt:P478
16
p:P356
wds:Q58659611-53B5939E-0495-406F-BBBA-46D6C2AAF9D3
wdtn:P356
n12:J.NMD.2006.03.002
wdt:P356
10.1016/J.NMD.2006.03.002